ArticleNature communications2022

Nationally representative SARS-CoV-2 antibody prevalence estimates after the first epidemic wave in Mexico.

Ana Basto-Abreu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.